Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 3, 2021
Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2)Homa Seyedmirzaei, Mahsa Keshavarz-Fathi, Sepideh Razi, et al.Cancer Immunology, Immunotherapy : CII|June 6, 2020
Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor siteElaheh Nasrollahzadeh, Sepideh Razi, Mahsa Keshavarz-Fathi, et al.Expert Opinion on Biological Therapy|April 28, 2022
Tumor-infiltrating lymphocyte therapy for lung cancer and its future paradigmsAli Nowroozi, Nastaran Khalili, Sepideh Razi, et al.Cytokine|March 26, 2020
Importance of TNF-alpha and its alterations in the development of cancersPouya Mahdavi Sharif, Parnian Jabbari, Sepideh Razi, et al.Journal of Environmental Health Science & Engineering|May 14, 2020
Effects of lead and cadmium on the immune system and cancer progressionMaryam Ebrahimi, Neda Khalili, Sepideh Razi, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 8, 2022
Nanoimmunoengineering strategies in cancer diagnosis and therapyRobabehbeygom Ghafelehbashi, Melina Farshbafnadi, Niloofar Shokraneh Aghdam, et al.Expert Review of Clinical Immunology|January 14, 2020
The NLRP3 inflammasome: a therapeutic target for inflammation-associated cancersMahdi Gouravani, Nastaran Khalili, Sepideh Razi, et al.Translational Lung Cancer Research|May 20, 2021
A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implicationsSahar Sadat Sedighzadeh, Amin Pastaki Khoshbin, Sepideh Razi, et al.Expert Opinion on Pharmacotherapy|July 13, 2021
Advances in pharmacotherapy for neuroblastomaParmida Sadat Pezeshki, Aysan Moeinafshar, Faezeh Ghaemdoust, et al.Clinical and Experimental Medicine|September 23, 2020
DCLK1, a promising colorectal cancer stem cell marker, regulates tumor progression and invasion through miR-137 and miR-15a dependent mannerSepideh Razi, Asieh Sadeghi, Zeynab Asadi-Lari, et al.Pageof 4